about
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-...
Read More
8.65
0.13
(1.53%)
944.8K
XNAS Volume
XNAS 11 Sep, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
89bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..